Article info
PDFLetter
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications
- Correspondence to Dr Raphaèle Seror, Université Paris-Sud, AP-HP, Hôpitaux Universitaires Paris-Sud, INSERM U1184, and Centre Hospitalier Universitaire de Bicêtre, Hôpital Bicêtre, Le Kremlin Bicêtre, France; raphaele.seror{at}aphp.fr
Citation
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications
Publication history
- Received February 4, 2018
- Revised July 1, 2018
- Accepted July 3, 2018
- First published July 20, 2018.
Online issue publication
November 16, 2018
Article Versions
- Previous version (16 November 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.